A Population-Based Study of Device Eligibility, Use, and Reasons for Nonimplantation in Patients at Heart Function Clinics-Reference-Cited by-同舟云学术

A Population-Based Study of Device Eligibility, Use, and Reasons for Nonimplantation in Patients at Heart Function Clinics

Published:2019-07 Issue:4 Volume:1 Page:173-181
ISSN:2589-790X
Container-title:CJC Open
language:en
Short-container-title:CJC Open

Author:

Bernier Rochelle,Ng Jessica,Tran Dat T.,Lockwood Evan,Reyes Lucy,Cowan Karen,Fine Nowell M.,Ezekowitz Justin,Exner Derek V.,Raj Satish R.,Sandhu Roopinder K.

Funder

Alberta Innovates Health Research

Boston Scientific

Medtronic Inc

GE healthcare

Abbott Laboratories

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction;Moss;N Engl J Med,2002

2. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia;Moss;N Engl J Med,1996

3. Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure;Bardy;N Engl J Med,2005

4. A randomized study of the prevention of sudden death in patients with coronary artery disease;Buxton;N Engl J Med,1999

5. Mode of induction of ventricular tachycardia and prognosis in patients with coronary disease: the multicenter UnSustained tachycardia trial (MUSTT);Piccini;J Cardiovasc Electrophysiol,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Associated With Non-Uptake of Implantable Cardioverter-Defibrillator (ICD) Among Eligible Patients at a Tertiary Hospital in Kenya;Global Heart;2024-08-16

2. Implantable cardioverter-defibrillator placement among patients with left ventricular ejection fraction ≤35 % at least 40 days after acute myocardial infarction;American Heart Journal Plus: Cardiology Research and Practice;2022-07

3. Patients' knowledge and concerns about using the implantable cardioverter defibrillator for the primary prevention of sudden cardiac death and its correlates: A cross‐sectional study;Health Science Reports;2022-06-13